{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:10:00Z","timestamp":1793985000334,"version":"4.8.0"},"reference-count":149,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2024,4,23]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>Postprandial, or meal-related, symptoms, such as abdominal pain, early satiation, fullness or bloating, are often reported by patients with disorders of gut-brain interaction, including functional dyspepsia (FD) or irritable bowel syndrome (IBS). We propose that postprandial symptoms arise via a distinct pathophysiological process. A physiological or psychological insult, for example, acute enteric infection, leads to loss of tolerance to a previously tolerated oral food antigen. This enables interaction of both the microbiota and the food antigen itself with the immune system, causing a localised immunological response, with activation of eosinophils and mast cells, and release of inflammatory mediators, including histamine and cytokines. These have more widespread systemic effects, including triggering nociceptive nerves and altering mood. Dietary interventions, including a diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols, elimination of potential food antigens or gluten, IgG food sensitivity diets or salicylate restriction may benefit some patients with IBS or FD. This could be because the restriction of these foods or dietary components modulates this pathophysiological process. Similarly, drugs including proton pump inhibitors, histamine-receptor antagonists, mast cell stabilisers or even tricyclic or tetracyclic antidepressants, which have anti-histaminergic actions, all of which are potential treatments for FD and IBS, act on one or more of these mechanisms. It seems unlikely that food antigens driving intestinal immune activation are the entire explanation for postprandial symptoms in FD and IBS. In others, fermentation of intestinal carbohydrates, with gas release altering reflex responses, adverse reactions to food chemicals, central mechanisms or nocebo effects may dominate. However, if the concept that postprandial symptoms arise from food antigens driving an immune response in the gastrointestinal tract in a subset of patients is correct, it is paradigm-shifting, because if the choice of treatment were based on one or more of these therapeutic targets, patient outcomes may be improved.<\/jats:p>","DOI":"10.1136\/gutjnl-2023-331833","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T13:16:11Z","timestamp":1714655771000},"page":"1199-1211","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":42,"title":["Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target"],"prefix":"10.1136","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6371-4359","authenticated-orcid":false,"given":"Alexander C","family":"Ford","sequence":"first","affiliation":[{"name":"Leeds Gastroenterology Institute, St James's University Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6704-2131","authenticated-orcid":false,"given":"Heidi M","family":"Staudacher","sequence":"additional","affiliation":[{"name":"Deakin University\u2014Geelong Waterfront Campus, Geelong, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2537-3092","authenticated-orcid":false,"given":"Nicholas J","family":"Talley","sequence":"additional","affiliation":[{"name":"Health, University of Newcastle, Callaghan, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"2025090711344026000_73.7.1199.1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"2025090711344026000_73.7.1199.2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S2468-1253(20)30217-X","article-title":"Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis","volume":"5","author":"Oka","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090711344026000_73.7.1199.3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/apt.16006","article-title":"Systematic review with meta-analysis: global prevalence of Uninvestigated dyspepsia according to the Rome criteria","volume":"52","author":"Barberio","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711344026000_73.7.1199.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01740.x"},{"key":"2025090711344026000_73.7.1199.5","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.099846"},{"key":"2025090711344026000_73.7.1199.6","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310004524"},{"key":"2025090711344026000_73.7.1199.7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/apt.17356","article-title":"Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome","volume":"57","author":"Goodoory","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711344026000_73.7.1199.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04640.x"},{"key":"2025090711344026000_73.7.1199.9","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12355"},{"key":"2025090711344026000_73.7.1199.10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/apt.16939","article-title":"Direct Healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom","volume":"56","author":"Goodoory","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711344026000_73.7.1199.11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/apt.17132","article-title":"Impact of Rome IV irritable bowel syndrome on work and activities of daily living","volume":"56","author":"Goodoory","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711344026000_73.7.1199.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.05.021"},{"key":"2025090711344026000_73.7.1199.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30469-4"},{"key":"2025090711344026000_73.7.1199.14","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(20)31548-8","article-title":"Irritable bowel syndrome","volume":"396","author":"Ford","year":"2020","journal-title":"Lancet"},{"key":"2025090711344026000_73.7.1199.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.03.035"},{"key":"2025090711344026000_73.7.1199.16","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(20)32115-2","article-title":"Functional gastrointestinal disorders: advances in understanding and management","volume":"396","author":"Black","year":"2020","journal-title":"Lancet"},{"key":"2025090711344026000_73.7.1199.17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S2468-1253(19)30348-6","article-title":"Stigma and irritable bowel syndrome: a taboo subject","volume":"5","author":"Hearn","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090711344026000_73.7.1199.18","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14080","article-title":"Deconstructing stigma as a barrier to treating DGBI: lessons for clinicians","volume":"33","author":"Feingold","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"2025090711344026000_73.7.1199.19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300474"},{"key":"2025090711344026000_73.7.1199.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-022-02259-7","article-title":"Global prevalence and burden of meal-related abdominal pain","volume":"20","author":"Colomier","year":"2022","journal-title":"BMC Med"},{"key":"2025090711344026000_73.7.1199.21","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.011"},{"key":"2025090711344026000_73.7.1199.22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.059"},{"key":"2025090711344026000_73.7.1199.23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/MCG.0b013e31815591f7","article-title":"Functional dyspepsia: not all roads seem to lead to Rome","volume":"43","author":"van Kerkhoven","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"2025090711344026000_73.7.1199.24","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.137125"},{"key":"2025090711344026000_73.7.1199.25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cgh.2019.07.053","article-title":"Analysis of postprandial symptom patterns in subgroups of patients with Rome III or Rome IV functional dyspepsia","volume":"18","author":"Carbone","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711344026000_73.7.1199.26","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/nmo.12585","article-title":"Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap","volume":"27","author":"Carbone","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"2025090711344026000_73.7.1199.27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S2468-1253(18)30003-7","article-title":"Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study","volume":"3","author":"Aziz","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090711344026000_73.7.1199.28","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308114"},{"key":"2025090711344026000_73.7.1199.29","doi-asserted-by":"publisher","DOI":"10.5056\/jnm.2014.20.1.104"},{"key":"2025090711344026000_73.7.1199.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07389.x"},{"key":"2025090711344026000_73.7.1199.31","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.078634"},{"key":"2025090711344026000_73.7.1199.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70012-5"},{"key":"2025090711344026000_73.7.1199.33","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1007\/s10620-011-1700-4","article-title":"Is the Colonic response to food different in IBS in contrast to simple constipation or diarrhea without abdominal pain","volume":"56","author":"Bouchoucha","year":"2011","journal-title":"Dig Dis Sci"},{"key":"2025090711344026000_73.7.1199.34","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1060928","article-title":"The relationship between fermentable carbohydrates and post-prandial bowel symptoms in patients with functional bowel disorders","volume":"10","author":"MacIntosh","year":"2023","journal-title":"Front Nutr"},{"key":"2025090711344026000_73.7.1199.35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MEG.0000000000000777","article-title":"Clinical, psychological, and physiological correlates of patients who Defecate after meal","volume":"29","author":"Bouchoucha","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025090711344026000_73.7.1199.36","doi-asserted-by":"publisher","DOI":"10.1177\/2050640613501817"},{"key":"2025090711344026000_73.7.1199.37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/nmo.12510","article-title":"Symptom-Association probability between meal ingestion and abdominal pain in patients with irritable bowel syndrome","volume":"27","author":"Arsi\u00e8","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"2025090711344026000_73.7.1199.38","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1053\/j.gastro.2015.11.010","article-title":"Depression and somatization are associated with increased postprandial symptoms in patients with irritable bowel syndrome","volume":"150","author":"Van Oudenhove","year":"2016","journal-title":"Gastroenterology"},{"key":"2025090711344026000_73.7.1199.39","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000103","article-title":"Measuring diet intake and gastrointestinal symptoms in irritable bowel syndrome: validation of the food and symptom times diary","volume":"10","author":"Wright-McNaughton","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"2025090711344026000_73.7.1199.40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2011.01802.x"},{"key":"2025090711344026000_73.7.1199.41","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14482","article-title":"Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome","volume":"35","author":"Algera","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"2025090711344026000_73.7.1199.42","doi-asserted-by":"publisher","DOI":"10.1053\/J.GASTRO.2016.02.031"},{"key":"2025090711344026000_73.7.1199.43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/apt.16812","article-title":"Gut-brain axis dysfunction underlies FODMAP-induced symptom generation in irritable bowel syndrome","volume":"55","author":"Wu","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711344026000_73.7.1199.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0377-0"},{"key":"2025090711344026000_73.7.1199.45","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301856"},{"key":"2025090711344026000_73.7.1199.46","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.512"},{"key":"2025090711344026000_73.7.1199.47","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.01.046"},{"key":"2025090711344026000_73.7.1199.48","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-022-02301-8","article-title":"Immune responses in the irritable bowel syndromes: time to consider the small intestine","volume":"20","author":"Burns","year":"2022","journal-title":"BMC Med"},{"key":"2025090711344026000_73.7.1199.49","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14109","article-title":"Duodenal eosinophilia and the link to anxiety: a population-based endoscopic study","volume":"33","author":"Ronkainen","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"2025090711344026000_73.7.1199.50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193542","article-title":"Anti-TNF alpha therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases","volume":"13","author":"Gray","year":"2018","journal-title":"PLoS One"},{"key":"2025090711344026000_73.7.1199.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.05.015"},{"key":"2025090711344026000_73.7.1199.52","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.cgh.2022.01.014","article-title":"Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies","volume":"20","author":"Shah","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711344026000_73.7.1199.53","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1053\/j.gastro.2020.12.016","article-title":"Proton pump inhibitors reduce duodenal eosinophilia, mast cells, and permeability in patients with functional dyspepsia","volume":"160","author":"Wauters","year":"2021","journal-title":"Gastroenterology"},{"key":"2025090711344026000_73.7.1199.54","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-011-0379-9"},{"key":"2025090711344026000_73.7.1199.55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03937.x"},{"key":"2025090711344026000_73.7.1199.56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1051632","article-title":"Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia","volume":"13","author":"Burns","year":"2022","journal-title":"Front Immunol"},{"key":"2025090711344026000_73.7.1199.57","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12846"},{"key":"2025090711344026000_73.7.1199.58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/pai.13000","article-title":"Non-IgE-mediated gastrointestinal allergies-do they have a place in a new model of the allergic March","volume":"30","author":"Meyer","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"2025090711344026000_73.7.1199.59","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181e85b55"},{"key":"2025090711344026000_73.7.1199.60","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/apt.12965","article-title":"Allergy-related diseases and recurrent abdominal pain during childhood - a birth cohort study","volume":"40","author":"Ol\u00e9n","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711344026000_73.7.1199.61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MPG.0000000000001219","article-title":"Preschoolers with allergic diseases have an increased risk of irritable bowel syndrome when reaching school age","volume":"64","author":"Tan","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025090711344026000_73.7.1199.62","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/pai.13440","article-title":"The natural course of cow\u2019s milk allergy and the development of atopic diseases into adulthood","volume":"32","author":"Hansen","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"2025090711344026000_73.7.1199.63","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cgh.2022.12.035","article-title":"AGA clinical practice update on alpha-gal syndrome for the GI clinician: commentary","volume":"21","author":"McGill","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711344026000_73.7.1199.64","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.03.046"},{"key":"2025090711344026000_73.7.1199.65","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.07.046"},{"key":"2025090711344026000_73.7.1199.66","doi-asserted-by":"crossref","first-page":"965","DOI":"10.14309\/ajg.0000000000001780","article-title":"Evidence-based and emerging dietary approaches to upper disorders of gut-brain interaction","volume":"117","author":"Tack","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2025090711344026000_73.7.1199.67","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000638","article-title":"Trav26-2 T-cell receptor expression is associated with mucosal lymphocyte response to wheat proteins in patients with functional dyspepsia","volume":"14","author":"Burns","year":"2023","journal-title":"Clin Transl Gastroenterol"},{"key":"2025090711344026000_73.7.1199.68","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03118-2"},{"key":"2025090711344026000_73.7.1199.69","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09964-7","article-title":"Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders","volume":"10","author":"Saffouri","year":"2019","journal-title":"Nat Commun"},{"key":"2025090711344026000_73.7.1199.70","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1116107"},{"key":"2025090711344026000_73.7.1199.71","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13622"},{"key":"2025090711344026000_73.7.1199.72","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312574"},{"key":"2025090711344026000_73.7.1199.73","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326158"},{"key":"2025090711344026000_73.7.1199.74","doi-asserted-by":"crossref","unstructured":"Kim SH , Choi Y , Oh J , et al . Associations among the duodenal ecosystem, gut microbiota, and nutrient intake in functional dyspepsia. Gut Liver 2023. doi:10.5009\/gnl230130","DOI":"10.5009\/gnl230130"},{"key":"2025090711344026000_73.7.1199.75","doi-asserted-by":"crossref","DOI":"10.1128\/MRA.00758-21","article-title":"Draft genome sequence of Streptococcus salivarius AGIRA0003, isolated from functional gastrointestinal disorder duodenal tissue","volume":"10","author":"Hoedt","year":"2021","journal-title":"Microbiol Resour Announc"},{"key":"2025090711344026000_73.7.1199.76","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2132078","article-title":"The Duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological Comorbidities in functional gastrointestinal disorders with and without self-reported non-celiac wheat sensitivity","volume":"14","author":"Shah","year":"2022","journal-title":"Gut Microbes"},{"key":"2025090711344026000_73.7.1199.77","doi-asserted-by":"publisher","DOI":"10.1177\/1535370214564748"},{"key":"2025090711344026000_73.7.1199.78","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-021-11263-5"},{"key":"2025090711344026000_73.7.1199.79","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbi.2022.01.019","article-title":"Defects in Nlrp6, autophagy and goblet cell homeostasis are associated with reduced duodenal CRH receptor 2 expression in patients with functional dyspepsia","volume":"101","author":"Bruce","year":"2022","journal-title":"Brain Behav Immun"},{"key":"2025090711344026000_73.7.1199.80","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13006"},{"key":"2025090711344026000_73.7.1199.81","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.12.039"},{"key":"2025090711344026000_73.7.1199.82","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/ajcn\/85.5.1185","article-title":"Histamine and histamine intolerance","volume":"85","author":"Maintz","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"2025090711344026000_73.7.1199.83","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj1895","article-title":"Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signaling in mice","volume":"14","author":"De Palma","year":"2022","journal-title":"Sci Transl Med"},{"key":"2025090711344026000_73.7.1199.84","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41587-020-0501-8","article-title":"A complete domain-to-species Taxonomy for bacteria and Archaea","volume":"38","author":"Parks","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2025090711344026000_73.7.1199.85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5414\/ALX02269E","article-title":"Guideline on management of suspected adverse reactions to ingested histamine: guideline of the German society for Allergology and clinical Immunology (DGAKI), the society for pediatric Allergology and environmental medicine (GPA), the medical Association of German Allergologists (Aeda) as well as the Swiss society for Allergology and Immunology (SGAI) and the Austrian society for Allergology and Immunology (\u00d6GAI)","volume":"5","author":"Reese","year":"2021","journal-title":"Allergol Select"},{"key":"2025090711344026000_73.7.1199.86","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.105"},{"key":"2025090711344026000_73.7.1199.87","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311339"},{"key":"2025090711344026000_73.7.1199.88","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327260"},{"key":"2025090711344026000_73.7.1199.89","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1907805"},{"key":"2025090711344026000_73.7.1199.90","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrgastro.2015.117","article-title":"Placebo effects and their determinants in gastrointestinal disorders","volume":"12","author":"Elsenbruch","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025090711344026000_73.7.1199.91","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S2468-1253(23)00317-5","article-title":"The effect of expectancy versus actual gluten intake on gastrointestinal and extra-intestinal symptoms in non-coeliac gluten sensitivity: a randomised, double-blind, placebo-controlled, International, multicentre study","volume":"9","author":"de Graaf","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090711344026000_73.7.1199.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.02.005"},{"key":"2025090711344026000_73.7.1199.93","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.11.039"},{"key":"2025090711344026000_73.7.1199.94","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303857"},{"key":"2025090711344026000_73.7.1199.95","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325214"},{"key":"2025090711344026000_73.7.1199.96","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/jgh.15694","article-title":"Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet versus traditional dietary advice for functional dyspepsia: a randomized controlled trial","volume":"37","author":"Goyal","year":"2022","journal-title":"J Gastro Hepatol"},{"key":"2025090711344026000_73.7.1199.97","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2016.09.062","article-title":"Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome","volume":"152","author":"Major","year":"2017","journal-title":"Gastroenterology"},{"key":"2025090711344026000_73.7.1199.98","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14148","article-title":"Epigastric symptom response to low FODMAP dietary advice compared with standard Dietetic advice in individuals with functional dyspepsia","volume":"33","author":"Staudacher","year":"2021","journal-title":"Neurogastroenterology Motil"},{"key":"2025090711344026000_73.7.1199.99","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1172\/JCI92390","article-title":"FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction","volume":"128","author":"Zhou","year":"2018","journal-title":"J Clin Invest"},{"key":"2025090711344026000_73.7.1199.100","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13675","article-title":"The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome","volume":"31","author":"Tuck","year":"2019","journal-title":"Neurogastroenterology Motil"},{"key":"2025090711344026000_73.7.1199.101","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15818"},{"key":"2025090711344026000_73.7.1199.102","doi-asserted-by":"crossref","unstructured":"Ajamian M , Rosella G , Newnham ED , et al . Effect of gluten ingestion and FODMAP restriction on intestinal epithelial integrity in patients with irritable bowel syndrome and self\u2010reported non\u2010coeliac gluten sensitivity. Molecular Nutrition Food Res 2021;65. doi:10.1002\/mnfr.201901275","DOI":"10.1002\/mnfr.201901275"},{"key":"2025090711344026000_73.7.1199.103","doi-asserted-by":"crossref","DOI":"10.3390\/nu13072469","article-title":"Psychological and gastrointestinal symptoms of patients with irritable bowel syndrome undergoing a low-FODMAP diet: the role of the intestinal barrier","volume":"13","author":"Prospero","year":"2021","journal-title":"Nutrients"},{"key":"2025090711344026000_73.7.1199.104","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13167","article-title":"Effect of intragastric FODMAP infusion on upper gastrointestinal motility, gastrointestinal, and psychological symptoms in irritable bowel syndrome vs healthy controls","volume":"30","author":"Masuy","year":"2018","journal-title":"Neurogastroenterology Motil"},{"key":"2025090711344026000_73.7.1199.105","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1273629","article-title":"Gluten restriction in irritable bowel syndrome, yes or no?: a GRADE-assessed systematic review and meta-analysis","volume":"10","author":"Arabpour","year":"2023","journal-title":"Front Nutr"},{"key":"2025090711344026000_73.7.1199.106","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3390\/nu12071947","article-title":"Wheat sensitivity and functional dyspepsia: a pilot, double-blind, randomized, placebo-controlled dietary crossover trial with novel challenge protocol","volume":"12","author":"Potter","year":"2020","journal-title":"Nutrients"},{"key":"2025090711344026000_73.7.1199.107","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/ajcn\/nqab337","article-title":"Fermentable oligo-, di-, monosaccharides, and polyols (Fodmaps), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial","volume":"115","author":"Nordin","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"2025090711344026000_73.7.1199.108","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.10.040"},{"key":"2025090711344026000_73.7.1199.109","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.3390\/jcm10194317","article-title":"Igg food antibody guided elimination-rotation diet was more effective than FODMAP diet and control diet in the treatment of women with mixed IBS: results from an open label study","volume":"10","author":"Ostrowska","year":"2021","journal-title":"JCM"},{"key":"2025090711344026000_73.7.1199.110","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.037697"},{"key":"2025090711344026000_73.7.1199.111","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-8-12"},{"key":"2025090711344026000_73.7.1199.112","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324598"},{"key":"2025090711344026000_73.7.1199.113","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001036"},{"key":"2025090711344026000_73.7.1199.114","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X11436241"},{"key":"2025090711344026000_73.7.1199.115","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01828-9"},{"key":"2025090711344026000_73.7.1199.116","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13601-015-0078-3","article-title":"Sensitivity to food additives, vaso-active amines and salicylates: a review of the evidence","volume":"5","author":"Skypala","year":"2015","journal-title":"Clinical & Translational All"},{"key":"2025090711344026000_73.7.1199.117","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.5694\/j.1326-5377.1984.tb133035.x","article-title":"Adverse reactions to foods","volume":"141","author":"Allen","year":"1984","journal-title":"Med J Aust"},{"key":"2025090711344026000_73.7.1199.118","first-page":"89","article-title":"Significance of Salicylate intolerance in diseases of the lower gastrointestinal tract","volume":"56 Suppl 5","author":"Raithel","year":"2005","journal-title":"J Physiol Pharmacol"},{"key":"2025090711344026000_73.7.1199.119","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jgh3.12578","article-title":"Naturally-occurring dietary salicylates in the genesis of functional gastrointestinal symptoms in patients with irritable bowel syndrome: pilot study","volume":"5","author":"Tuck","year":"2021","journal-title":"JGH Open"},{"key":"2025090711344026000_73.7.1199.120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jhn.12385","article-title":"British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults","volume":"29","author":"McKenzie","year":"2016","journal-title":"J Human Nutrition Diet"},{"key":"2025090711344026000_73.7.1199.121","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp16X686521"},{"key":"2025090711344026000_73.7.1199.122","doi-asserted-by":"crossref","DOI":"10.3390\/nu11071684","article-title":"Food intolerances","volume":"11","author":"Tuck","year":"2019","journal-title":"Nutrients"},{"key":"2025090711344026000_73.7.1199.123","doi-asserted-by":"crossref","first-page":"985","DOI":"10.14309\/ajg.0000000000001766","article-title":"Psychological considerations in the dietary management of patients with DGBI","volume":"117","author":"Murray","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2025090711344026000_73.7.1199.124","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/MCG.0000000000001575","article-title":"Improving medication tolerance: a pilot study in disorders of gut-brain interaction treated with tricyclic antidepressants","volume":"56","author":"Ballou","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"2025090711344026000_73.7.1199.125","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/apt.17111","article-title":"Review article: exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome","volume":"56","author":"Biesiekierski","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711344026000_73.7.1199.126","doi-asserted-by":"publisher","DOI":"10.1159\/000490354"},{"key":"2025090711344026000_73.7.1199.127","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327737"},{"key":"2025090711344026000_73.7.1199.128","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF01536059","article-title":"Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis","volume":"34","author":"Collen","year":"1989","journal-title":"Digest Dis Sci"},{"key":"2025090711344026000_73.7.1199.129","doi-asserted-by":"crossref","unstructured":"Pinto-Sanchez MI , Yuan Y , Bercik P , et al . Proton pump inhibitors for functional dyspepsia. Cochrane Database Syst Rev 2017;CD011194. doi:10.1002\/14651858.CD011194.pub2","DOI":"10.1002\/14651858.CD011194.pub2"},{"key":"2025090711344026000_73.7.1199.130","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16072"},{"key":"2025090711344026000_73.7.1199.131","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302250"},{"key":"2025090711344026000_73.7.1199.132","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.09.019"},{"key":"2025090711344026000_73.7.1199.133","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/j.gastro.2022.12.015","article-title":"High discovery rate of duodenal and gastric eosinophilia in patients with unexplained moderate-severe abdominal symptoms: a prospective US multisite study","volume":"164","author":"Talley","year":"2023","journal-title":"Gastroenterology"},{"key":"2025090711344026000_73.7.1199.134","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316878"},{"key":"2025090711344026000_73.7.1199.135","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/apt.16396","article-title":"Letter: budesonide for functional dyspepsia with duodenal eosinophilia-randomised, double-blind, placebo-controlled parallel-group trial","volume":"53","author":"Talley","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090711344026000_73.7.1199.136","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329873"},{"key":"2025090711344026000_73.7.1199.137","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","article-title":"Anti-Siglec-8 antibody for eosinophilic gastritis and duodenitis","volume":"383","author":"Dellon","year":"2020","journal-title":"N Engl J Med"},{"key":"2025090711344026000_73.7.1199.138","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2019-318412","article-title":"Dual histamine blockade for the treatment of adult functional dyspepsia: a single centre experience","volume":"69","author":"Potter","year":"2020","journal-title":"Gut"},{"key":"2025090711344026000_73.7.1199.139","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.12.034"},{"key":"2025090711344026000_73.7.1199.140","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-331634"},{"key":"2025090711344026000_73.7.1199.141","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.213108"},{"key":"2025090711344026000_73.7.1199.142","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/MEG.0000000000001737","article-title":"Clinical efficacy and safety of Ketotifen in treating irritable bowel syndrome with diarrhea","volume":"32","author":"Wang","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025090711344026000_73.7.1199.143","doi-asserted-by":"publisher","DOI":"10.1177\/2050640617691690"},{"key":"2025090711344026000_73.7.1199.144","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0222-5"},{"key":"2025090711344026000_73.7.1199.145","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(23)01523-4","article-title":"Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"402","author":"Ford","year":"2023","journal-title":"Lancet"},{"key":"2025090711344026000_73.7.1199.146","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310721"},{"key":"2025090711344026000_73.7.1199.147","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.020"},{"key":"2025090711344026000_73.7.1199.148","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.09.043"},{"key":"2025090711344026000_73.7.1199.149","doi-asserted-by":"crossref","DOI":"10.1186\/s13030-021-00205-2","article-title":"A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome","volume":"15","author":"Khalilian","year":"2021","journal-title":"Biopsychosoc Med"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2023-331833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T18:34:56Z","timestamp":1757270096000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2023-331833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":149,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,6,6]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/gutjnl-2023-331833"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2023-331833","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]}}}